Literature DB >> 66113

Splitting of human thyroglobulin. IV. The antigenicity of the pepsin-derived fragments.

W A Stylos, N R Rose.   

Abstract

Purified human thyroglobulin (Tg) was hydrolysed by pepsin. After completion of hydrolysis the pepsin hydrolysate was passed through a Sephadex G-200 column to remove undigested Tg. Further isolation of the enzymatic fragments was effected by passage through a Sephadex G-75 column. Two discrete fragments, termed pep I and pep II, were separated. The two fragments had sedimentation coefficients of 1-0 and 0-6, respectively. These fragments retained antigenic determinants reactive with both hetero-and auto-antibodies to Tg. The larger fragment, pep I, possessed all antigenic determinants to intact Tg while pep II lacked some determinants. Neither fragment contained novel determinants resulting from proteolytic degradation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66113      PMCID: PMC1540784     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY.

Authors:  L ORNSTEIN
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

3.  Studies on organ specificity. IV. Production of rabbit thyroid antibodies in the rabbit.

Authors:  E WITEBSKY; N R ROSE
Journal:  J Immunol       Date:  1956-06       Impact factor: 5.422

4.  The properties of thyroglobulin. VII. The immunoloic activity of thyroglobulin fragments.

Authors:  H METZGER; G C SHARP; H EDELHOCH
Journal:  Biochemistry       Date:  1962-03       Impact factor: 3.162

5.  The immunoreaction of auto- and heteroantisera with modified human thyroglobulin.

Authors:  G B Salabè; C Davoli; S Fontana
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

6.  Studies on thyroid proteins. 3. Precipitating activity of autoimmune and heteroimmune antisera with human thyroglobulin.

Authors:  G P Mates; S Shulman
Journal:  Immunochemistry       Date:  1967-09

7.  Splitting of human thyroglobulin. II. Enzymatic digestion.

Authors:  W A Stylos; N R Rose
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

8.  Studies on thyroid proteins. VII. Immunochemical properties of some enzymatic fragments of rabbit thyroglobulin.

Authors:  M Ghayasuddin; S Shulman
Journal:  Immunology       Date:  1970-08       Impact factor: 7.397

9.  Ultracentrifugal and immunological comparisons of succinylated human thyroglobulin and 27 S iodoprotein.

Authors:  D J Smith; S Shulman
Journal:  Immunol Commun       Date:  1973

10.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

View more
  5 in total

1.  Antigenic determinants of human thyroglobulin differentiated using antigen fragments.

Authors:  D K Male; B R Champion; G Pryce; H Matthews; P Shepherd
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

2.  Isolation and properties of a succinylated subunit of human thyroglobulin.

Authors:  D J Smith; S Shulman
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Restrictions in the response to autologous thyroglobulin in the human.

Authors:  L Nye; L C Pontes de Carvalho; I M Roitt
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

4.  Tryptic peptides of human thyroglobulin: I. Immunoreactivity with murine monoclonal antibodies.

Authors:  A M Saboori; C L Burek; N R Rose; H S Bresler; M Talor; R C Kuppers
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

5.  Tryptic peptides of human thyroglobulin: II. Immunoreactivity with sera from patients with thyroid diseases.

Authors:  A M Saboori; P Caturegli; N R Rose; S Mariotti; A Pinchera; C L Burek
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.